Proven Pancreatic Cancer Patient Recruitment Results
Our specialized pancreatic cancer recruitment platform delivers faster enrollment across all tumor types and treatment settings.
Comprehensive Pancreatic Cancer Patient Recruitment
Expert recruitment across all pancreatic cancer types and treatment lines for accelerated clinical trial enrollment.
Pancreatic Ductal Adenocarcinoma (PDAC)
Most common pancreatic cancer type recruitment across all stages and treatment lines
Metastatic Pancreatic Cancer
Advanced stage pancreatic cancer recruitment for breakthrough therapies and combination studies
Pancreatic Neuroendocrine Tumors (PNET)
Specialized recruitment for pancreatic NETs across all grades and functional status
Resectable Pancreatic Cancer
Early-stage pancreatic cancer recruitment for neoadjuvant and adjuvant therapy trials
BRCA-Mutant Pancreatic Cancer
Germline BRCA mutation carriers requiring PARP inhibitor and targeted therapy trials
Locally Advanced Pancreatic Cancer
Borderline resectable and locally advanced disease recruitment for intensive treatments
Advanced Pancreatic Cancer Recruitment Strategies
Multi-channel approach combining digital outreach, gastroenterology networks, and patient advocacy partnerships.
Digital Patient Outreach
Targeted campaigns reaching pancreatic cancer patients through social media, search marketing, and patient portals
Pancreatic Cancer Networks
Direct relationships with pancreatic surgeons, gastroenterologists, and pancreatic cancer centers
Patient Advocacy Collaboration
Partnerships with pancreatic cancer foundations, support groups, and advocacy organizations
Molecular Testing Coordination
BRCA, KRAS, microsatellite instability testing for precision recruitment strategies